Noven Pharmaceuticals Overview

  • Founded

  • 1987

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 300

Employees
  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 2

  • Investments

  • 4

Noven Pharmaceuticals General Information

Description

Manufacturer of prescription pharmaceutical products intended to patient care through transdermal drug delivery. The company is primarily focused on the areas of women's health and mental health, including ADHD and schizophrenia.

Contact Information

Website
www.noven.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Parent Company
Hisamitsu Pharmaceutical
Primary Office
  • 11960 South West
  • 144th Street
  • Miami, FL 33186
  • United States
+1 (305) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Noven Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Noven Pharmaceuticals‘s full profile, request access.

Request a free trial

Noven Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of prescription pharmaceutical products intended to patient care through transdermal drug delivery. The com
Pharmaceuticals
Miami, FL
300 As of 2023
0000 0000-00-00
000000&0

000000

ua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut a
000000000000000
Dublin, Ireland
0000 As of 0000
00.000
000000000 00.000

0000 0

luptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaec
000000000000000
Monmouth Junction, NJ
000 As of 0000
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Noven Pharmaceuticals Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alkermes Formerly VC-backed Dublin, Ireland 0000 00.000 000000000 00.000
0000 000000 Private Debt Financed Monmouth Junction, NJ 000 000000000 -
00000 Corporation Mumbai, India 00000 00000000
000000 00000000 Corporation Tokyo, Japan 00000 00.000 00000000 00.000
000000 00000000000 Formerly PE-Backed Oakville, Canada 0 00000 000000&0
You’re viewing 5 of 15 competitors. Get the full list »

Noven Pharmaceuticals Patents

  • 464

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 32

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Noven Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11572339-B2 Amphetamine carbamate compounds and methods Active 07-Jan-2021 0000000000 00
US-20220213029-A1 Amphetamine carbamate compounds and methods Active 07-Jan-2021 0000000000
US-20220218628-A1 Transdermal amphetamine compositions with low levels of carbamate Active 07-Jan-2021 0000000000 0
US-11559501-B2 Transdermal amphetamine compositions with low levels of carbamate Active 07-Jan-2021 0000000000 00
US-20190192662-A1 Transdermal pharmaceutical compositions with reduced skin irritation Inactive 22-Dec-2017 A61K47/22
To view Noven Pharmaceuticals’s complete patent history, request access »

Noven Pharmaceuticals Executive Team (6)

Name Title Board Seat Contact Info
Naruhito Higo Chairman & Chief Executive Officer
John Choi Vice President, Chief Financial Officer & Treasurer
Joel Lippman MD Board Member, Chief Operating Officer & Chief Medical Officer
You’re viewing 3 of 6 executive team members. Get the full list »

Noven Pharmaceuticals Board Members (1)

Name Representing Role Since
00000000 0000 Noven Pharmaceuticals Chairman & Chief Executive Officer 000 0000
To view Noven Pharmaceuticals’s complete board members history, request access »

Noven Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Noven Pharmaceuticals Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 000000000 15-Aug-2007 0000000000 00000 Pharmaceuticals
0000000 00000 20-Mar-2007 00000 0000 0000 Surgical Devices 000000 00
0000000 00000 31-Jan-2003 00000 0000 0000 Surgical Devices 000000 00
Salient Surgical Technologies 15-Jan-2002 Later Stage VC 000.00 Surgical Devices 000000 00
To view Noven Pharmaceuticals’s complete investments and acquisitions history, request access »

Noven Pharmaceuticals Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 00000000 0 20-Mar-2007 00000 00000 00 0000 Completed
  • 10 buyers
0000000 00000000 0 31-Jan-2003 00000 00000 00 0000 Completed
  • 9 buyers
Salient Surgical Technologies 15-Jan-2002 Later Stage VC 000.00 Completed
  • 14 buyers
To view Noven Pharmaceuticals’s complete exits history, request access »